|
Market Closed -
Other stock markets
|
After hours 19:38:59 | |||
| 38.30 USD | +0.98% |
|
37.40 | -2.36% |
| 06-18 | Barclays Initiates Indivior at Overweight With $46 Price Target | MT |
| 06-10 | Indivior Pharmaceuticals Insider Sold Shares Worth $1,357,200, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 38.48 | 40.61 | 39.5 |
| Spread/Res. | -0.47% | -5.69% | -3.04% |
| Spread/Supp. | +6.54% | +33.08% | +32.21% |
| Support | 35.95 | 28.78 | 28.97 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- INDV Stock
- Charts Indivior Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
